Tower Research Capital LLC (Trc) Arrowhead Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 37,792 shares of ARWR stock, worth $753,950. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,792
Previous 9,120
314.39%
Holding current value
$753,950
Previous $176,000
303.41%
% of portfolio
0.01%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding ARWR
# of Institutions
304Shares Held
96.2MCall Options Held
388KPut Options Held
420K-
Black Rock Inc. New York, NY15.7MShares$313 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$243 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$222 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$120 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$104 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.11B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...